- Home
- ELEV vs HUIZ Comparison
ELEV vs HUIZ Comparison
Compare ELEV & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- HUIZ
- Stock Information
- Founded
- ELEV 2019
- HUIZ 2006
- Country
- ELEV United States
- HUIZ China
- Employees
- ELEV N/A
- HUIZ N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- ELEV Health Care
- HUIZ Finance
- Exchange
- ELEV Nasdaq
- HUIZ Nasdaq
- Market Cap
- ELEV 20.0M
- HUIZ 18.8M
- IPO Year
- ELEV 2021
- HUIZ 2020
- Fundamental
- Price
- ELEV $0.34
- HUIZ $2.26
- Analyst Decision
- ELEV Buy
- HUIZ
- Analyst Count
- ELEV 6
- HUIZ 0
- Target Price
- ELEV $2.94
- HUIZ N/A
- AVG Volume (30 Days)
- ELEV 975.2K
- HUIZ 65.5K
- Earning Date
- ELEV 05-23-2025
- HUIZ 05-27-2025
- Dividend Yield
- ELEV N/A
- HUIZ N/A
- EPS Growth
- ELEV N/A
- HUIZ N/A
- EPS
- ELEV N/A
- HUIZ N/A
- Revenue
- ELEV N/A
- HUIZ $171,105,205.00
- Revenue This Year
- ELEV N/A
- HUIZ $6.81
- Revenue Next Year
- ELEV N/A
- HUIZ $9.30
- P/E Ratio
- ELEV N/A
- HUIZ N/A
- Revenue Growth
- ELEV N/A
- HUIZ 4.46
- 52 Week Low
- ELEV $0.22
- HUIZ $1.50
- 52 Week High
- ELEV $4.33
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- ELEV 48.18
- HUIZ 54.25
- Support Level
- ELEV $0.33
- HUIZ $2.10
- Resistance Level
- ELEV $0.37
- HUIZ $2.43
- Average True Range (ATR)
- ELEV 0.03
- HUIZ 0.29
- MACD
- ELEV 0.00
- HUIZ 0.06
- Stochastic Oscillator
- ELEV 25.54
- HUIZ 73.44
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.